TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 27604769

Group type: EXPERIMENTAL
Intervention: Prenatal multiple micronutrient (MM) supplementation
Number of subjects: 8529

Group type: COMPARATOR
Intervention: Iron-folic acid (IFA) supplementation
Number of subjects: 8529
Study: 24496084

Group type: EXPERIMENTAL
Intervention: Exercise intervention (EXE) - combined aerobic and resistance workouts, 6 days/week for 60 minutes/day
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (CON) - maintained sedentary lifestyle
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Both groups (EXE and CON)
Number of subjects: 28
Study: 21106607

Group type: EXPERIMENTAL
Intervention: Diazepam (10 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 20337772

Group type: EXPERIMENTAL
Intervention: Isotretinoin 0.3 mg/kg
Number of subjects: 573

Group type: COMPARATOR
Intervention: Doxycycline
Number of subjects: 573

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 573
Study: 18837861

Group type: EXPERIMENTAL
Intervention: BCM (manual‐based medical care model)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 58
Study: 15820533

Group type: EXPERIMENTAL
Intervention: 750 mg of metyrapone
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 40 mg of cocaine
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 12
Study: 12915938

Group type: EXPERIMENTAL
Intervention: SDS‐pore PAGE
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 58
Study: 10482089

Group type: EXPERIMENTAL
Intervention: latanoprost 0.005% given at 10 PM
Number of subjects: 34

Group type: COMPARATOR
Intervention: timolol 0.5%, twice daily
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: latanoprost 0.005% given at 8 AM
Number of subjects: 34
Study: 8739868

Group type: EXPERIMENTAL
Intervention: Pressurized seawater
Number of subjects: 20

Group type: COMPARATOR
Intervention: Antiseptic-mucolytic saline
Number of subjects: 20
Study: 1754859

Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg twice daily for 6 weeks (double-blind alternating treatment)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Placebo for 6 weeks (double-blind alternating treatment)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Ranitidine continued for 4 weeks (single-blind treatment)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Placebo until relapse or maximum 8 weeks (single-blind treatment)
Number of subjects: 115
Study: 7102530

Group type: EXPERIMENTAL
Intervention: pindolol (5 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: metoprolol (100 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: inhaled fenoterol (0.4 mg)
Number of subjects: 12
Study: 31948000

Group type: EXPERIMENTAL
Intervention: Dynamic Vibration Rolling (DVR)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Vibration Rolling (VR)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Static Stretching (SS)
Number of subjects: 20

Group type: COMPARATOR
Intervention: DVR compared to SS
Number of subjects: 20

Group type: COMPARATOR
Intervention: VR compared to SS
Number of subjects: 20

Group type: COMPARATOR
Intervention: DVR compared to VR
Number of subjects: 20
Study: 31448738

Group type: EXPERIMENTAL
Intervention: Polypill group (hydrochlorothiazide 12·5 mg, aspirin 81 mg, atorvastatin 20 mg, and enalapril 5 mg or valsartan 40 mg)
Number of subjects: 6838

Group type: COMPARATOR
Intervention: Minimal care group (non-pharmacological preventive interventions)
Number of subjects: 6838

Group type: EXPERIMENTAL
Intervention: Polypill group (high adherence)
Number of subjects: 6838

Group type: EXPERIMENTAL
Intervention: Polypill group
Number of subjects: 6838

Group type: COMPARATOR
Intervention: Minimal care group
Number of subjects: 6838
Study: 29427230

Group type: EXPERIMENTAL
Intervention: Self-report of recent infection (≤ 6 months)
Number of subjects: 1137

Group type: EXPERIMENTAL
Intervention: MAA classification for individuals diagnosed within 6 months (unknown duration)
Number of subjects: 1137

Group type: COMPARATOR
Intervention: Control group (diagnosed ≥ 2 years before randomization)
Number of subjects: 1137

Group type: EXPERIMENTAL
Intervention: Participants recently infected by self-report and/or MAA
Number of subjects: 1137
Study: 27506485

Group type: EXPERIMENTAL
Intervention: Overminus spectacles (-2.50 D over cycloplegic refraction)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Observation (non-overminus spectacles if needed or no spectacles)
Number of subjects: 58
Study: 25052784

Group type: EXPERIMENTAL
Intervention: Telephone-administered cognitive-behavioral therapy (T-CBT)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Face-to-face cognitive-behavioral therapy (CBT)
Number of subjects: 103
Study: 23225299

Group type: EXPERIMENTAL
Intervention: Impact + resistance exercise (POWIR)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Low-intensity stretching (FLEX)
Number of subjects: 106
Study: 20972656

Group type: EXPERIMENTAL
Intervention: Epoetin zeta
Number of subjects: 481

Group type: COMPARATOR
Intervention: Epoetin alfa
Number of subjects: 481
Study: 18855174

Group type: EXPERIMENTAL
Intervention: Fear of falling at baseline
Number of subjects: 321

Group type: COMPARATOR
Intervention: Depression at baseline
Number of subjects: 321

Group type: EXPERIMENTAL
Intervention: Social functioning
Number of subjects: 321
Study: 15797312

Group type: EXPERIMENTAL
Intervention: Astronauts during flight
Number of subjects: 32

Group type: COMPARATOR
Intervention: Healthy age-matched control subjects
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Astronauts (10 days before flight and on landing day)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Astronauts on landing day
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Limited study (n=5) on landing day
Number of subjects: 32
Study: 12201922

Group type: EXPERIMENTAL
Intervention: Transurethral interstitial laser coagulation (ILC)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Transurethral microwave thermotherapy (TUMT)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Transurethral resection or incision of the prostate (TUR-P/TUI-P)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Comparison of TUMT and TUR-P/TUI-P
Number of subjects: 118
Study: 10710122

Group type: EXPERIMENTAL
Intervention: UR-7247 2.5 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: UR-7247 5 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: UR-7247 10 mg
Number of subjects: 16

Group type: COMPARATOR
Intervention: Losartan 100 mg
Number of subjects: 16
Study: 9015796

Group type: EXPERIMENTAL
Intervention: 100 mg/kg phenylalanine
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 8195856

Group type: EXPERIMENTAL
Intervention: Brodimoprim, 200 mg once-a-day on the first day and 100 mg once-a-day on the following days
Number of subjects: 78

Group type: COMPARATOR
Intervention: Cefaclor, 40 mg/Kg/day in three doses
Number of subjects: 78
Study: 3529357

Group type: EXPERIMENTAL
Intervention: Glucagon
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Glucagon-(1-21)-peptide
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 30860547

Group type: EXPERIMENTAL
Intervention: Panretinal Photocoagulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intravitreous Ranibizumab
Number of subjects: 0
Study: 29989185

Group type: EXPERIMENTAL
Intervention: EAM-guided pacemaker implantation into RVAPS (EAM-RVAPS)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Conventional fluoroscopic-guided implantation into RV apex (RVA)
Number of subjects: 21
Study: 28089902

Group type: EXPERIMENTAL
Intervention: Olmesartan 20 mg plus azelnidipine 16 mg
Number of subjects: 28

Group type: COMPARATOR
Intervention: Olmesartan 20 mg plus trichlormethiazide 1 mg
Number of subjects: 28
Study: 25596097

Group type: EXPERIMENTAL
Intervention: Educational guideline for aerobic exercise and stretching
Number of subjects: 34
Study: 24265770

Group type: EXPERIMENTAL
Intervention: Transcutaneous Electrical Nerve Stimulation (TENS)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Neuromuscular Electro Stimulation (NMES)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 22
Study: 20852905

Group type: EXPERIMENTAL
Intervention: BCAA supplementation (AEN group, n = 48)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Conventional diet (control group, n = 48)
Number of subjects: 96
Study: 18339052

Group type: EXPERIMENTAL
Intervention: Calcium carbonate combined with vitamins C (500 mg) and B(6) (75 mg) and proline
Number of subjects: 60

Group type: COMPARATOR
Intervention: Calcium carbonate alone
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 16580765

Group type: EXPERIMENTAL
Intervention: Rivastigmine
Number of subjects: 18
Study: 12662184

Group type: EXPERIMENTAL
Intervention: RPR100893 (1 mg)
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: RPR100893 (5 mg)
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: RPR100893 (20 mg)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 139
Study: 11218053

Group type: EXPERIMENTAL
Intervention: Topiramate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9385040

Group type: EXPERIMENTAL
Intervention: KAKKONTO coadministration (group K)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Acetaminophen (APAP) administration (group A)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: KAKKONTO at 100 mg/kg (group K) in rats
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: KAKKONTO at two different doses
Number of subjects: 0
Study: 1333097

Group type: EXPERIMENTAL
Intervention: Vitamin K treatment during the last 6 weeks prior to delivery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Untreated women
Number of subjects: 0

Group type: COMPARATOR
Intervention: Both placebo and vitamin K groups
Number of subjects: 0
Study: 31722337

Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Subcutaneous immunotherapy (SCIT)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study: 31468342

Group type: EXPERIMENTAL
Intervention: Consult condition (workshop plus ability to place a medical order for an interview from a consultation‐liaison service)
Number of subjects: 1173

Group type: COMPARATOR
Intervention: Workshop only
Number of subjects: 1173

Group type: COMPARATOR
Intervention: Apprenticeship condition (workshop plus bedside supervision)
Number of subjects: 1173

Group type: EXPERIMENTAL
Intervention: Consult condition
Number of subjects: 1173

Group type: EXPERIMENTAL
Intervention: All conditions
Number of subjects: 1173
Study: 28641925

Group type: EXPERIMENTAL
Intervention: 3g oral ManNAc
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 6g oral ManNAc
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 10g oral ManNAc
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 25537481

Group type: EXPERIMENTAL
Intervention: Pasireotide (300-1,200 μg bid)
Number of subjects: 58
Study: 23887841

Group type: EXPERIMENTAL
Intervention: Combination therapy (0.6 mg/kg rt-PA plus eptifibatide 135 mcg/kg bolus and a 2-hour infusion at 0.75 mcg/kg per minute)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Standard rt-PA (0.9 mg/kg)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 126

Group type: COMPARATOR
Intervention: Standard rt-PA
Number of subjects: 126
Study: 24303381

Group type: EXPERIMENTAL
Intervention: 1 mg/kg ketamine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 60
Study: 20609652

Group type: EXPERIMENTAL
Intervention: Nebivolol
Number of subjects: 2128

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2128
Study: 18219958

Group type: EXPERIMENTAL
Intervention: Erespall (fenspirid)
Number of subjects: 0
Study: 15759215

Group type: EXPERIMENTAL
Intervention: Pushrim-activated power-assist wheelchair (PAPAW)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Traditional manual wheelchair
Number of subjects: 15
Study: 11941556

Group type: EXPERIMENTAL
Intervention: lamivudine treatment
Number of subjects: 43
Study: 9579106

Group type: EXPERIMENTAL
Intervention: Signal probability level of .01
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Signal probability level of .04
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Signal probability level of .12
Number of subjects: 3
Study: 8744700

Group type: EXPERIMENTAL
Intervention: Domperidone administration
Number of subjects: 0
Study: 2666707

Group type: EXPERIMENTAL
Intervention: Dilzem (180‐300 mg/daily)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Corinfar (30‐60 mg/daily)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 998645

Group type: EXPERIMENTAL
Intervention: Lidocaine 1% preparation
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Lidocaine 2% preparation
Number of subjects: 25

Group type: COMPARATOR
Intervention: Lidocaine 0.25% preparation
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25

Group type: COMPARATOR
Intervention: Lidocaine 0.50% preparation
Number of subjects: 25

Group type: COMPARATOR
Intervention: Lidocaine 0.75% preparation
Number of subjects: 25

Group type: COMPARATOR
Intervention: Lidocaine 1.0% preparation
Number of subjects: 25
Study: 31347165

Group type: EXPERIMENTAL
Intervention: Khorasan-based diet
Number of subjects: 20

Group type: COMPARATOR
Intervention: Modern semi-whole-grain wheat
Number of subjects: 20
Study: 30731375

Group type: EXPERIMENTAL
Intervention: Antibiotics use
Number of subjects: 39782

Group type: EXPERIMENTAL
Intervention: Outdoor NO2 and PM10, ETS, gas cooking, burning biomass, incense, and mosquito coils
Number of subjects: 39782
Study: 28599898

Group type: EXPERIMENTAL
Intervention: Chlorhexidine-alcohol 26-mL single-step applicator
Number of subjects: 932

Group type: COMPARATOR
Intervention: Povidone-iodine aqueous scrub and paint 236-mL wet skin tray
Number of subjects: 932
Study: 26463012

Group type: EXPERIMENTAL
Intervention: Dignity Therapy (DT)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Counseling
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 70
Study: 25071065

Group type: EXPERIMENTAL
Intervention: NHS Health Checks
Number of subjects: 16669

Group type: COMPARATOR
Intervention: Usual medical care (Control)
Number of subjects: 16669
Study: 22511916

Group type: EXPERIMENTAL
Intervention: Daily oral FTC/TDF
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Intermittent oral FTC/TDF (Monday, Friday and within 2 hours after sex)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Post-coital doses of FTC/TDF
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 19445642

Group type: EXPERIMENTAL
Intervention: Auricular acupuncture (Group A, n = 23)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Sham auricular acupuncture (Group B, n = 22)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Auricular acupuncture (Group A)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Sham auricular acupuncture (Group B)
Number of subjects: 45
Study: 17264174

Group type: EXPERIMENTAL
Intervention: 3-month structured exercise training (ET) program
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (untrained)
Number of subjects: 90
Study: 14704540

Group type: EXPERIMENTAL
Intervention: Ellipse Standard Deviation (ESD)
Number of subjects: 504

Group type: EXPERIMENTAL
Intervention: Normalized Superior Area (NSA)
Number of subjects: 504

Group type: EXPERIMENTAL
Intervention: Normalized Inferior Area (NIA)
Number of subjects: 504

Group type: EXPERIMENTAL
Intervention: Discriminant Analysis (DA)
Number of subjects: 504

Group type: COMPARATOR
Intervention: The Number (existing parameter)
Number of subjects: 504
Study: 11474327

Group type: EXPERIMENTAL
Intervention: Endurance training (EX)
Number of subjects: 31
Study: 9571346

Group type: EXPERIMENTAL
Intervention: Low-intensity laser irradiation (30 J/cm2)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham irradiation
Number of subjects: 30
Study: 8053584

Group type: EXPERIMENTAL
Intervention: Epidural sufentanil infusion at 0.2 microgram.kg‐1.h‐1
Number of subjects: 50

Group type: COMPARATOR
Intervention: Intravenous sufentanil infusion at 0.2 microgram.kg‐1.h‐1
Number of subjects: 50
Study: 2927302

Group type: EXPERIMENTAL
Intervention: Glucose polymers (3 g.kg‐1 in a 50% solution)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo (artificially sweetened)
Number of subjects: 6
Study: 31743467

Group type: EXPERIMENTAL
Intervention: HEPA air cleaner
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo 'dummy' treatment
Number of subjects: 43
Study: 31815656

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral intervention via online multimedia video game with smartphone app companion
Number of subjects: 548

Group type: COMPARATOR
Intervention: Control group receiving online information on active aging
Number of subjects: 548
Study: 28576675

Group type: EXPERIMENTAL
Intervention: Buparlisib plus fulvestrant
Number of subjects: 1147

Group type: COMPARATOR
Intervention: Placebo plus fulvestrant
Number of subjects: 1147

Group type: EXPERIMENTAL
Intervention: Buparlisib
Number of subjects: 1147

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1147
Study: 26423375

Group type: EXPERIMENTAL
Intervention: Nurse-led palliative care intervention (assessments of physical, emotional, and spiritual wellbeing and quality of life) given six times over 4 months.
Number of subjects: 120

Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 120
Study: 23859389

Group type: EXPERIMENTAL
Intervention: Inhaling ketamine 1 mg/kg (Group Ki)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of ketamine 1 mg/kg (Group Kv)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Inhaling normal saline 10 ml (Group C)
Number of subjects: 90
Study: 22585697

Group type: EXPERIMENTAL
Intervention: Clofarabine plus cytarabine (Clo+Ara‐C arm)
Number of subjects: 320

Group type: COMPARATOR
Intervention: Cytarabine (Ara‐C arm)
Number of subjects: 320
Study: 18534440

Group type: EXPERIMENTAL
Intervention: Rim cutter
Number of subjects: 40
Study: 17103207

Group type: EXPERIMENTAL
Intervention: Visual imagery task
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Tactile imagery task
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Mental computation task
Number of subjects: 30

Group type: COMPARATOR
Intervention: Cognitive tasks (visual and tactile imagery)
Number of subjects: 30
Study: 15961421

Group type: EXPERIMENTAL
Intervention: Velocity‐dependent force field (VF) introduced for sets of three consecutive trials.
Number of subjects: 0
Study: 12354090

Group type: EXPERIMENTAL
Intervention: New toothbrush
Number of subjects: 40

Group type: COMPARATOR
Intervention: 3-month-old toothbrush
Number of subjects: 40
Study: 10400422

Group type: EXPERIMENTAL
Intervention: ATRA (All-Trans Retinoic Acid)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: As2O3 (Arsenic Trioxide)
Number of subjects: 0

Group type: COMPARATOR
Intervention: DNR (Daunorubicin)
Number of subjects: 0
Study: 7549366

Group type: EXPERIMENTAL
Intervention: Clonidine 3 micrograms/kg 10 min before induction
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 2044734

Group type: EXPERIMENTAL
Intervention: Bricanyl Turbuhaler (dry powder terbutaline 0.5 mg q.i.d)
Number of subjects: 258

Group type: COMPARATOR
Intervention: Bricanyl metered dose inhaler (MDI) (terbutaline 0.5 mg q.i.d)
Number of subjects: 258
Study: 6166799

Group type: EXPERIMENTAL
Intervention: Suloctidil
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Suloctidil and Placebo
Number of subjects: 45
Study: 31330899

Group type: EXPERIMENTAL
Intervention: Vitamin D + Phenylbutyrate
Number of subjects: 167
Study: 29099626

Group type: EXPERIMENTAL
Intervention: Structured self-monitoring of blood glucose (SMBG)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Control group (no SMBG)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Structured SMBG
Number of subjects: 250
Study: 25958709

Group type: EXPERIMENTAL
Intervention: Antibiotics discontinued promptly after CRP level < 10 mg/L in group Ia
Number of subjects: 98

Group type: COMPARATOR
Intervention: Antibiotics continued until all bacterial cultures were negative in group Ib
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Antibiotics continued until CRP < 10 mg/L in group IIa
Number of subjects: 98

Group type: COMPARATOR
Intervention: Antibiotics continued until all bacterial cultures were negative in group IIb
Number of subjects: 98
Study: 23587364

Group type: EXPERIMENTAL
Intervention: Dietary intervention consisting of 7 individual nutrition consulting sessions (approximately 60 minutes each) delivered by an Accredited Practising Dietitian (APD) focusing on a healthy diet based on the Australian Dietary Guidelines and the Dietary Guidelines for Adults in Greece.
Number of subjects: 176

Group type: COMPARATOR
Intervention: Social support group (befriending protocol) with the same visit schedule and length as the diet intervention.
Number of subjects: 176
Study: 21978220

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 32
Study: 19857666

Group type: EXPERIMENTAL
Intervention: Mycophenolic acid (MPA) C(0) levels below 1.0 to 1.5 microg/mL at day 7
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: MPA C(0) levels
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: MPAG C(0) levels above 100 to 150 microg/mL at day 7
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: MPAG C(0) levels
Number of subjects: 42
Study: 17098132

Group type: EXPERIMENTAL
Intervention: Exercise (graded supine bicycle exercise at 25 W and 50 W)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Rest
Number of subjects: 40
Study: 15113721

Group type: EXPERIMENTAL
Intervention: Zinc supplementation (25 mg Zn)
Number of subjects: 242

Group type: COMPARATOR
Intervention: Control group (without zinc supplementation)
Number of subjects: 242
Study: 11340212

Group type: EXPERIMENTAL
Intervention: Intravenous thrombolysis
Number of subjects: 75
Study: 9117505

Group type: EXPERIMENTAL
Intervention: Psychoeducational workshops (single-session)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Workshop attendance
Number of subjects: 132
Study: 7913986

Group type: EXPERIMENTAL
Intervention: Zidovudine (ZDV) administered antenatally, intrapartum, and postnatally
Number of subjects: 0